Dr. Marshall J. Glesby | Source | Professor of Medicine, Professor of Population Health Sciences at Weill Corne...
Dr. Marshall J. Glesby
Dr. Marshall is a Professor of Medicine and Population Health Sciences, Director of the Weill Cornell HIV Clinical Trials Unit, and Associate Chief of the Division of Infectious Diseases in the Department of Medicine at Weill Cornell Medicine. He is also the Director of the Clinical and Translational Resource Unit Core of the Weill Cornell Clinical and Translational Science Center.
-
Smoking rates are at least double among people living with HIV, about 30 to 40 percent compared to 13 percent for individuals who are HIV-negative. However, even after adjusting for smoking status, emphysema is more severe and progresses faster in individuals with HIV than in those who are HIV-negative.
-
NIH Grant Funds Antibiotic Trial for Patients with HIV and Emphysema
Weill Cornell Medicine has been awarded a five-year, $7.8 million grant from the National Heart, Lung, and Blood Institute, part of the National Institutes of Health, to study whether the antibiotic doxycycline may slow the progression of the chronic lung disease emphysema in people living with well-controlled HIV.
Article
-
Weill Cornell Medicine
Professor of Medicine, Professor of Population Health Sciences